Top Markets
Coin of the day
Chongqing Taiji Industry(Group) Co.,Ltd Chongqing Taiji Industry(Group) Co.,Ltd

Chongqing Taiji Industry(Group) Co.,Ltd

600129
Rank in Stocks #8908
Chongqing Taiji Industry (Group) Co.,Ltd operates as a pharmaceutical... Chongqing Taiji Industry (Group) Co.,Ltd operates as a pharmaceutical enterprise, conducting business both within China and across international markets. The company focuses on the research, development, manufacturing, and distribution of traditional Chinese medicines and various health products. Its offerings are available in a wide array of formats, including tablets, oral liquids, syrups, dripping pills, granules, capsules, tinctures, and powders. The product line addresses a comprehensive range of health conditions and therapeutic areas. These include disorders of the digestive and respiratory systems, cardiovascular and cerebrovascular ailments, pediatric and gynecological health, systemic anti-infective agents and antibiotics, pain relief medications, orthopedic treatments, remedies for colds and coughs, and drugs for the endocrine and nervous systems. The firm's headquarters are situated in Chongqing, China.
Share Price
$2.07
Last synced: 2026-08-28
Market Cap
$1.14B
Change (1 day)
-1.31%
Change (1 year)
-33.77%
Country
CN
Trade Chongqing Taiji Industry(Group) Co.,Ltd (600129)

Category

Number of shares outstanding for Chongqing Taiji Industry(Group) Co.,Ltd (600129)
Number of shares outstanding as of August 2026: 0
According to Chongqing Taiji Industry(Group) Co.,Ltd latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Chongqing Taiji Industry(Group) Co.,Ltd (600129) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors